Search

everythinglearnresearchcommunity

for

Search:↓

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

The plant extract mixture improves skin health by reducing inflammation, boosting collagen, and supporting anti-aging.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Microbiome analysis, BEVs, and AI can improve PCOS diagnosis and treatment.

Chicken feather gene mutation helps understand human hair disorders.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New acne treatments show promise as alternatives to traditional therapies.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.